StockData
Bright Minds Biosciences Inc. logo

Bright Minds Biosciences Inc. (DRUG) stock

DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 23, 2025Score 5/30
$20.70−0.06 (-0.29%)

Close on Nov 19, 2026Market cap $158.06MP/E –Yield –

Bright Minds Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Bright Minds Biosciences's market cap was $161.29M on Nov 11, 2026, against $301.71M a year earlier. Over the last 5 years it ranged from $3.31M to $605.75M, with a median of $17.23M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$161.29M-70.0%
2025Dec 31, 2025$536.76M+245.7%
2024Dec 31, 2024$155.25M+2818.7%
2023Dec 29, 2023$5.32M-41.8%
2022Dec 30, 2022$9.14M-67.9%
2021Dec 31, 2021$28.45M–

More Bright Minds Biosciences figures

See a number that looks wrong?